Life sciences R&D

We enable life sciences companies to accelerate their R&D processes and enhance their healthcare economic analyses by harnessing the power of rich, longitudinal anonymised patient data.

Our partnerships with leading NHS Trusts allow us access to anonymised patient data.

We curate and analyse this data using proprietary AI methods providing answers to complex clinical questions.

These insights help to accelerate the discovery and development of new medicines and medical devices, to improve patient care and reduce healthcare costs.

Let's work together

Our unique business model provides us with access to real-world data that is unparalleled in its breadth and depth. If you would like to explore how your R&D or post-launch activities could benefit from the insights we can provide, please contact us.

Contact us

NHS data for life sciences research

An ethically sourced database providing a rich source of clinical data while protecting patient privacy.

Find out more

World-class, clinically validated AI

We make sense of huge quantities of real-world data to extract actionable insights.

Learn more about our Clinical AI

World-class, clinically validated AI

We make sense of huge quantities of real-world data to extract actionable insights.

Learn more about our Clinical AI

‘Bedside to bench’ development

Our AI-driven analysis of real-world anonymised patient data has potential to transform the classic R&D pipeline into a cyclical process, enabling more precise target selection and accelerating multiple stages of development. 

Drug development stages diagram

Drug target selection

By analysing phenotypic data from electronic patient clinical records combined with genomics and other -omics data we can provide pharmaceutical companies with new insights and target opportunities.

Precision clinical trial design

The insights we produce from analysis of real-world anonymised patient data and panomics can inform clinical trial design by identifying more targeted populations, providing time and cost savings and increasing the likelihood of successful trials.

Post-launch research & monitoring

We provide insights to support the post-launch phase of a particular drug or device, providing opportunities for broader application of existing treatments or devices, or for new healthcare economics analyses to inform pricing or reimbursement strategies.  

Let's work together

If you're interested in partnering with us or have a project you'd like to discuss, contact us.

Contact us